Barclays lowered the firm’s price target on D.R. Horton (DHI) to $128 from $129 and keeps an Equal Weight rating on the shares. The firm adjusted targets in the homebuilding and building products space as part of a Q1 earnings preview. Barclays favors building products and distributor names with pricing power and/or vertical integration. Investors should continue to avoid homebuilders as 2026 “shapes up to be a potential lost year,” the analyst tells investors in a research note.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DHI:
- D.R. Horton downgraded to Neutral from Buy at Seaport Research
- U.S. Mortgage Rates Ramp to 6-Month High as Spring Home-Buying Season Kicks Off
- DR Horton Expands Credit Facilities to Boost Liquidity
- Forestar Group assumed with a Neutral at BTIG
- U.S. Mortgage Rates Leap to 6-Month High as U.S.-Iran War Fuels Inflation Fears